Abstract
[Co2(HL1)2(H2O)2](NO3) (1), [Cu2(H2L1)(HL1) (CH3COO)]·H2O (2), [Cu4(HL1)4(C2H5OH)]·C2H5OH·H2O (3), and [Mn3(HL2)2(CH3OH)2(CH3COO)4]·2(CH3OH)·H2O (4) {H3L1 = 2-ethyl-2-(2-hydroxybenzylideneamino)propane-1,3-diol, H3L2 = 2-ethyl-2-[(2-hydroxynaphthalene-1-yl)methyleneamino]propane-1,3-diol} have been synthesized and characterized by IR spectra, elemental analyses, single-crystal X-ray diffraction, TGA, XRD, and magnetic measurements. Compound 1 possesses mixed-valence dinuclear {Co2(μ2-O)2} with Co(II) and Co(III) ions linked through μ2-hydroxyl of Schiff base ligands. Compound 2 displays a binuclear structure with {Cu2(μ2-O)(η2-COO)} containing one μ2-hydroxyl and a single syn–syn acetate bridge. Compound 3 is tetranuclear with a cube-shaped {Cu4(μ3-O)4} core constructed by four Cu(II) centers and four μ3-hydroxyls of Schiff base ligands. Compound 4 displays a linear trinuclear {Mn3(μ2-O)2(η2-COO)2} structure in which the terminal Mn(III) and the central Mn(II) ions are linked by a μ2-hydroxyl of Schiff base and two syn–syn acetate bridges. The results show that terminal hydroxyl groups of Schiff base ligands play an important role in assembling polynuclear compounds. Magnetic properties and antitumor activities of these compounds were investigated. The antitumor activities reveal that 1 and 2 are more effective antitumor agents for K-562 and HL-60, respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.